You are here
Clear Scientific, LLC
UEI: USCME5Z4GVN7
# of Employees: 17
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Stable Antimicrobial Formulation of Scopolamine for Multi-dose Vial
Amount: $167,489.52Recent efforts to improve treatment for nerve agent poisoning include the development of a scopolamine hydrobromide injectable as an anticholinergic. A scopolamine injectable would add an extremely be ...
SBIRPhase I2022Department of Defense Office for Chemical and Biological Defense -
A novel therapeutic approach for treatment of acute intoxication by co-use of opioids and stimulants
Amount: $319,695.00Project Summary/Abstract This effort addresses the urgent need for a therapeutic agent that effectively and rapidly reverses the toxic effects caused by co-use of multiple substances. Opioid use in th ...
SBIRPhase I2022Department of Health and Human Services National Institutes of Health -
An oral therapeutic to treat intoxication by prescription and illicit stimulants
Amount: $319,946.00Project Summary/Abstract There is a significant unmet medical need to sequester and remove orally ingested prescription and illicit stimulants from the gastrointestinal (GI) tract, to prevent and trea ...
SBIRPhase I2022Department of Health and Human Services National Institutes of Health -
Fieldable decontamination system for sensitive equipment
Amount: $549,857.70The ability for a warfighter to quickly and effectively decontaminate chemical and biological agents on sensitive equipment in the field can significantly improve the readiness and effectiveness of th ...
SBIRPhase II2021Department of Defense Office for Chemical and Biological Defense -
Production of a stable recombinant human butyrylcholinesterase
Amount: $558,524.50Human butyrylcholinesterase (BChE) is an effective bioscavenger of organophosphates and has potential for acting as a pre-exposure prophylactic or post-exposure treatment for organophosphate (OP) nerv ...
SBIRPhase II2021Department of Defense Office for Chemical and Biological Defense -
Opioid Indicator Spray for Complex Surfaces
Amount: $167,446.38Opioids, especially synthetic opioids, are a constant threat to the safety of civilian first responders; there are now serious concerns about their use in modern chemical warfare. Fentanyl and its man ...
STTRPhase I2021Department of Defense Office for Chemical and Biological Defense -
On-Demand Printing of Hazardous Compound Sensors
Amount: $111,459.93A growing myriad of chemical hazards pose substantial threats to the warfighter, with limited options for fieldable kits that can address the breadth and range of such hazards without placing undue bu ...
SBIRPhase I2021Department of Defense Army -
Novel Therapeutic Agents to Reverse Opioid Overdose
Amount: $2,529,335.00Project Summary/Abstract This effort addresses the urgent need for a safe rapidly acting reversal agent for fentanyl and its analogues (F/FA) with a mechanism of action that differs from the ยต-opioid ...
SBIRPhase II2021Department of Health and Human Services National Institutes of Health -
Novel Therapeutic Agents to Reverse Opioid Overdose
Amount: $224,889.00Project Summary/Abstract The abuse of opioids is a serious national crisis that affects public health as well as social and economic welfare. A 2018 report from the Centers for Disease Control and Pre ...
SBIRPhase I2020Department of Health and Human Services National Institutes of Health -
Fieldable decontamination system for sensitive equipment
Amount: $167,474.81The ability for a warfighter to quickly and effectively decontaminate chemical and biological agents on sensitive equipment in the field can significantly improve the readiness and effectiveness of th ...
SBIRPhase I2020Department of Defense Office for Chemical and Biological Defense
